AAAAAA
Results:
1-12
|
Results: 12
Authors:
CHI L
SAGANEK LJ
ROGERS KL
MERTZ TE
METZ AL
UPRICHARD ACG
GALLAGHER KP
Citation: L. Chi et al., A NOVEL MODEL OF VENOUS THROMBOSIS IN THE VENA-CAVA OF RABBITS, Journal of pharmacological and toxicological methods, 39(4), 1998, pp. 193-202
Authors:
JANICZEK N
SMITH DE
CHANG T
VENTURA A
MERTZ TE
Citation: N. Janiczek et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF PIRMENOL ENANTIOMERS IN CORONARY-ARTERY LIGATED DOGS, Journal of pharmaceutical sciences, 86(4), 1997, pp. 443-449
Authors:
MCCLANAHAN TB
IGNASIAK DP
MERTZ TE
JUNEAU PL
KIM IC
KIM GP
Citation: Tb. Mcclanahan et al., THE ANTITHROMBOTIC EFFECTS OF LB30057 IN THE CANINE MODEL OF ELECTROLYTICALLY-INDUCED VENOUS THROMBOSIS, Circulation, 96(8), 1997, pp. 215-215
Authors:
MCCLANAHAN TB
MERTZ TE
IGNASIAK DP
JUNEAU PL
GALLAGHER KP
Citation: Tb. Mcclanahan et al., EFFECTS OF ENDOTHELIN(A) RECEPTOR ANTAGONISM WITH PD156707 ON MYOCARDIAL STUNNING IN SWINE, The FASEB journal, 10(3), 1996, pp. 1866-1866
Authors:
MCCLANAHAN TB
MERTZ TE
IGNASIAK DP
JUNEAU PL
GALLAGHER KP
Citation: Tb. Mcclanahan et al., EFFECTS OF ENDOTHELIN-RECEPTOR ANTAGONISM WITH PD156707 ON MYOCARDIALSTUNNING IN SWINE, Journal of cardiovascular pharmacology, 28(5), 1996, pp. 679-686
Authors:
MERTZ TE
MCCLANAHAN TB
FLYNN MA
JUNEAU P
REYNOLDS EE
HALLAK H
BRADFORD L
GALLAGHER KP
Citation: Te. Mertz et al., ENDOTHELIN(A) RECEPTOR ANTAGONISM BY PD-156707 DOES NOT REDUCE INFARCT SIZE AFTER CORONARY-ARTERY OCCLUSION REPERFUSION IN PIGS/, The Journal of pharmacology and experimental therapeutics, 278(1), 1996, pp. 42-49
Authors:
MCCLANAHAN TB
IGNASIAK DP
MARTIN BJ
MERTZ TE
GALLAGHER KP
Citation: Tb. Mcclanahan et al., EFFECT OF ADENOSINE-DEAMINASE INHIBITION WITH PENTOSTATIN ON MYOCARDIAL STUNNING IN DOGS, Basic research in cardiology, 90(2), 1995, pp. 176-183
Authors:
LOW JE
METZ AL
MERTZ TE
HENRY SP
KNOWLTON P
LOEWEN G
SOMMERS CS
ROBERTSON DG
OLSZEWSKI BJ
SCHROEDER RL
GOUGH AW
KEISER J
MANN D
Citation: Je. Low et al., CARDIAC-HYPERTROPHY IN RATS AFTER INTRAVENOUS ADMINISTRATION OF CI-959, A NOVEL ANTIINFLAMMATORY COMPOUND - MORPHOLOGIC FEATURES AND PHARMACOKINETIC AND PHARMACODYNAMIC MECHANISMS, Journal of cardiovascular pharmacology, 25(6), 1995, pp. 930-939
Authors:
MERTZ TE
MCCLANAHAN TB
FLYNN MA
REYNOLDS EE
BRADFORD L
HALLAK H
GALLAGHER KP
Citation: Te. Mertz et al., ENDOTHELIN(A) RECEPTOR ANTAGONISM BY PD156707 DOES NOT REDUCE INFARCTSIZE FOLLOWING CORONARY-ARTERY OCCLUSION-REPERFUSION IN PIGS, Circulation, 92(8), 1995, pp. 2173-2173
Authors:
MCCLANAHAN TB
MERTZ TE
MARTIN BJ
GALLAGHER KP
Citation: Tb. Mcclanahan et al., PENTOSTATIN REDUCES INFARCT SIZE IN PIGS ONLY WHEN COMBINED WITH MILDHYPOTHERMIA, Circulation, 90(4), 1994, pp. 478-478
Authors:
MCCLANAHAN TB
MERTZ TE
MARTIN BJ
GALLAGHER KP
Citation: Tb. Mcclanahan et al., PENTOSTATIN REDUCES INFARCT SIZE IN PIGS ONLY WHEN COMBINED WITH MILDHYPOTHERMIA, Circulation, 90(4), 1994, pp. 478-478
Authors:
MCCLANAHAN TB
IGNASIAK DP
MARTIN BJ
MERTZ TE
GALLAGHER KP
Citation: Tb. Mcclanahan et al., INHIBITION OF ADENOSINE-DEAMINASE WITH PENTOSTATIN ATTENUATES MYOCARDIAL STUNNING IN DOGS, Circulation, 88(4), 1993, pp. 187-187
Risultati:
1-12
|